Bioethics News

Here’s How 23andMe Hopes to Make Drugs from Your Spit Samples

(Time) – On March 12, 23andMe, the genetic testing company best known for analyzing your DNA from a sample of spit, announced the creation of a new therapeutics group. The group’s mission: to find and develop drugs from the world’s largest database of human genetic material. That’s a huge shift for the company, which must now build a research and development arm from scratch.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.